+ Follow INTERNATIONAL CONSENSUS COMMITTEE Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 149435
[Title] => Innovative drug for enlarged prostate
[Summary] => A potent non-surgical alternative for the treatment of enlarged prostate or Benign Prostatic Hyperplasia (BPH) was unveiled at a press conference at the EDSA Shangri-La Hotel recently.
A new once-daily formulation that uses the unique Geomatrix Technology delivery system, Xatral OD is a triple-layered extended release tablet with the active drug alfuzosine HCI contained within a matrix between two non-active layers.
[DatePublished] => 2002-02-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
INTERNATIONAL CONSENSUS COMMITTEE
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 149435
[Title] => Innovative drug for enlarged prostate
[Summary] => A potent non-surgical alternative for the treatment of enlarged prostate or Benign Prostatic Hyperplasia (BPH) was unveiled at a press conference at the EDSA Shangri-La Hotel recently.
A new once-daily formulation that uses the unique Geomatrix Technology delivery system, Xatral OD is a triple-layered extended release tablet with the active drug alfuzosine HCI contained within a matrix between two non-active layers.
[DatePublished] => 2002-02-04 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
February 4, 2002 - 12:00am